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Abstract
Cancer-associated fibroblasts (CAF) play a crucial role in regulating cancer progression,
yet the molecular determinant that governs the tumor regulatory role of CAF remains
unknown. Using a mouse melanoma model in which exogenous melanoma cells were
grafted on the skin of two lines of mice where the genetic activation or inactivation of Notch1
signaling specifically occurs in natural host stromal fibroblasts, we demonstrated that
Notch1 pathway activity could determine the tumor-promoting or tumor-suppressing pheno-
type in CAF. CAF carrying elevated Notch1 activity significantly inhibited melanoma growth
and invasion, while those with a null Notch1 promoted melanoma invasion. These findings
identify the Notch1 pathway as a molecular determinant that controls the regulatory role of
CAF in melanoma skin growth and invasion, unveiling Notch1 signaling as a potential thera-
peutic target for melanoma and potentially other solid tumors.
Introduction
CAF are stromal fibroblasts residing within and in the vicinity of the tumor mass. They are pri-
marily derived from activated local quiescent fibroblasts and recruited circulating bone marrow
mesenchymal stem cells (MSC) [1,2]. CAF are involved in regulating tumor progression by
eliciting soluble factors, extracellular matrix (ECM) [3] and exosomes [4]. Their contribution
to primary and secondary malignancies [5,6] as well as taking part in drug resistance and
tumor recurrence [7,8] make CAF potential targets for therapeutic interventions on the tumor
microenvironment (TME). Despite extensive evidence supporting the crucial tumor-regulating
role of CAF, how the role is determined remains a mystery. We and others previously observed
that Notch1 pathway activity is inversely correlated with that of fibroblasts. Notch pathway
activity is low in proliferating fibroblasts, while high in quiescent fibroblasts [9]. Loss of Notch1
in mouse embryonic fibroblasts (MEF) resulted in faster cell growth and motility rate, whereas
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Notch1 activation retarded cell growth and motility of human fibroblasts [9]. Consistently,
Notch activation induced cell-cycle arrest and apoptosis in MEF [10]. In tumor xenograft
mouse models, co-implanted experimental human dermal fibroblasts carrying high Notch1
activity inhibited melanoma growth and angiogenesis [11], demonstrating that Notch1 activa-
tion confers a tumor-suppressive phenotype on experimental CAF. These results suggested a
crucial role for Notch signaling in governing function of fibroblasts. However, the fibroblasts
investigated in these earlier studies are not real or natural CAF. Here we utilized novel mouse
models to explore the role of Notch1 signaling in determining the regulatory role of natural
host CAF in melanoma growth and invasion.
Materials and Methods
Mice
Notch1Loxp/LoxPmice were described [12]. ROSALSL-N1IC+/+ (#008159) and Fsp1.Cre+/- (#012641)
mice were purchased from The Jackson Lab (Bar Harbor, ME). All these mice have a C57BL6
background. The Gain-Of-Function Notch1 (GOFNotch1: Fsp1.Cre+/-;ROSALSL-N1IC+/+) and Loss-
Of-Function Notch1 (LOFNotch1: Fsp1.Cre+/-;Notch1LoxP/LoxP+/+) lines were generated by crossing
ROSALSL-N1IC+/+ andNotch1Loxp/LoxP+/+ with Fsp1.Cre+/-mice, and subsequently crossing Fsp1.
Cre+/-;ROSALSL-N1IC+/-with ROSALSL-N1IC+/+mice and Fsp1.Cre+/-;Notch1LoxP/LoxP+/- withNot-
ch1Loxp/LoxP+/+ mice, respectively. GOFctrl (FSP1.Cre-/-;ROSALSL-N1IC+/+) and LOFctrl (FSP1.Cre-/-;
Notch1LoxP/LoxP+/+) mice were used as control. Mice were maintained at the DVR animal facility
under standard conditions. Mice were anesthetized for all surgical procedures by ketamine/xyla-
zine mixture (100/10 mg/kg, IP), and imaging procedures by inhaling 3% isoflurane gas, and sac-
rificed in CO2 chamber. Institutional animal care and use committee at the University of Miami
approved all animal procedures.
Mouse skin model of melanoma
Murine melanoma cells, B16-F10 (ATCC1, CRL-67345TM), stably transduced with Luciferase
2 (Luc2)/lentivirus, were cultured with complete DMEM. For tumor graft experiments, 5 x 105
Luc2+/B16-F10 cells suspended in 0.1 ml saline were inoculated (s.c.) on dorsal skin of 6-week
old GOFNotch1 vs. GOFctrl and 8-week old LOFNotch1 vs. LOFctrl mice. B-16-F10 are derived
from C57BL6 mouse and can be xenografted on the created GOF, LOF and control mice which
have a C57BL6 background. The mice were sacrificed at week 3 after grafting. Resected tumors
were weighted. Melanoma growth was assessed based on tumor weight and positivity of Ki67
cell proliferation marker measured by immunofluorescence in tumor cells, while melanoma
local invasion was evaluated by histological assessment of tissue sections of resected
melanoma.
Histology, Immunofluorescence (IF) & Western blot
H&E and IF were performed as described [11]. Antibodies recognize activated Notch1, Hes1,
Ki67, Luc (ab8925, ab71559, ab15580, ab81823, Abcam, Cambridge, MA), Hey-1, and FSP1
(GTX42614, GTX89197, GeneTex, Irvine, CA). Nuclei were stained with DAPI (Sigma-
Aldrich, St. Louis, MO). Quantifications are mean ± standard deviation (SD) of counts from 5
low power field (LPF) per tumor sample for H&E staining, and 5 high power field (HPF) per
section and 5 section/tumor for IF staining. For Western blot, skin tissue samples were homog-
enized in a RIPA buffer (50 mM Tris-Cl, 150 mM sodium chloride 1.0% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, pH 8.0, 1 mM EDTA and protease inhibitor cocktails (Roche)). The
tissue suspension was rotated at 4°C for 30 min. Supernatants were collected after
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centrifugation at 13,000 rpm for 15 min. Concentration of protein was determined using Pier-
ceTM BCA Protein Assay Kit (#23225). Western blot was conducted as described [11]. Expres-
sion of mutant N1IC (muN1IC, 59Kd) and deletion of Notch1 in mouse skin were detected by
two different anti-Notch1 antibodies, respectively (ab8925 and ab52627, Abcam).
Bioluminescence imaging of IVIS
D-luciferin was injected intra-peritoneally 15 minutes prior to imaging (150mg/kg). Whole-
body of anesthetized mice were scanned using IVIS 200B (PerkinElmer, Waltham, MA) with a
1 minute capture, medium binning. Bioluminescence signal was quantified and reported as
total light emission within the region of interest (photon/s).
Lentivirus and cell transduction
Luc2+/lentiviral vector was constructed by inserting Luc2 cDNA into pLenti6 (Invitrogene)
vector. Production of lentivirus and transduction of cells were performed as described [13].
Statistical analysis
The data were statistically analyzed using two-tailed Student’s t-test and expressed as the
mean ± SD. The values are considered statistically significant when p<0.05.
Results
Notch1 activation in CAF suppresses melanoma growth
Expression of fibroblast-specific protein-1 (FSP1, also called S100A4) is generally restricted to
fibroblasts [14,15]. FSP1.Cremice were successfully used to create null alleles in fibroblasts for
TGFβ type II receptors [16], EP4 receptors [17], and PTEN [18]. We created the 1st pair of
GOFNotch1 vs. GOFctrl mice. GOFNotch1 mice were viable until employed in melanoma skin
graft experiments within two months. Their body appearance and skin tissue histology, includ-
ing dermis where skin fibroblasts primarily reside, appeared normal (S1A Fig).
To examine the role of CAF with high Notch1 activity in regulating melanoma growth, 5 x
105 Luc2+/B16-F10 cells were inoculated onto skin of GOFNotch1 vs. GOFctrl mice. In this
model, the cellular components of entire tumor stroma, including CAF, are composed of natu-
ral host cells. Tumor metastasis was monitored by whole-body IVIS scanning at week 3 post
tumor inoculations. Skin tumors were resected, weighted and subjected to immunohistochemi-
cal analysis after IVIS scanning.
IF staining of skin sections portrayed confined and elevated expression of N1IC in nuclei of
FSP1+ fibroblasts of GOFNotch1 mice compared with GOFctrl mice (Fig 1A), but not in adjacent
skin muscle cells (notably muscle cells presented autofluorescence yet no nuclear signals were
detectable). Similarly, Hey1 expression was increased in nuclei of FSP1+ skin fibroblasts of
GOFNotch1 mice relative to GOFctrl mice (S1B Fig). Moreover, the expression of transgene-
encoded mutant N1IC protein (muN1IC: PEST domain-truncated N1IC, 59 Kd, (ROSALSL-N1IC+/+,
The Jackson Lab: #008159)) in skin of GOFNotch1 mice was confirmed byWestern blotting (Fig
1B). These results demonstrated efficient Cre-mediated specific expression of N1IC and Notch
pathway activation in skin fibroblasts.
Melanoma growth in GOFNotch1 mice was significantly retarded in comparison to that in
GOFctrl mice (Fig 1C). Consistently, there were substantially less Ki67+ tumor cells (Luc2+) in
melanoma tissues from GOFNotch1 than from GOFctrl mice (Fig 1D). Proliferative activity
(Ki67 positivity) of melanoma cells was particularly weaker when adjacent to CAF (Fig 1E),
suggesting that CAF carrying high Notch1 activity in GOFNotch1 mice might release tumor
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suppressive factor(s). These results demonstrated that Notch1 activation confers a tumor-sup-
pressive phenotype on CAF.
Notch1 activation in CAF suppresses melanoma invasion
Since spreading melanoma cells must interact with fibroblasts located in the skin dermis (and
in the vicinity of engrafted melanoma), fibroblasts may have a significant impact on melanoma
dissemination. We further studied the effect of CAF on melanoma invasion and metastasis in
GOFNotch1 mice. Melanoma local invasion was evaluated by histological assessment of tissue
sections of resected melanoma. H&E staining of resected melanoma tissues illustrated that
83.3% of melanoma had local invasion into adjacent skin tissues in GOFctrl mice compared
Fig 1. CAF retardsmelanoma growth in GOFNotch1 mice. A. Representative images show expression of N1IC in nuclei (arrowheads pointed) of FSP1+ skin
fibroblasts of GOFNotch1 vs. GOFctrl mice. B. Expression of transgene-encodedmuN1IC (59 Kd) in skin of GOFNotch1 mice was detected byWestern blotting.
β–actin was used as loading control.C. Melanoma growth is retarded in GOFNotch1 mice (n = 8/group). Five representative images of resected tumors/group
are displayed. D. Substantially less Ki67+ tumor cells (Luc2+) per HPF in melanoma from GOFNotch1 than GOFctrl mice. E. Proliferative activity of melanoma
cells (Ki67+) is particularly low in the area (marked) adjacent to CAF (FSP1+) in GOFNotch1 mice. Quantifications are counts from 5 HPF per section and 5
section/tumor. The data were statistically analyzed using two-tailed Student’s t-test and expressed as the mean ± SD.
doi:10.1371/journal.pone.0142815.g001
Notch1 Determines Tumor-Regulating Role of CAF
PLOSONE | DOI:10.1371/journal.pone.0142815 November 12, 2015 4 / 11
with 22.2% in GOFNotch1 mice (Fig 2A). However, IVIS scan of whole-body and harvested
organs, including lung, liver, spleen, kidney and femur, did not yield measurable luminescent
signals (data not shown), which suggest that no distant metastasis occurred at the time of our
assay. IF revealed that CAF in tumor capsule displayed lower proliferative activity (less Ki67+/
FSP1+ cells) in GOFNotch1 than in GOFctrl mice (Fig 2B & 2C). These data indicate that CAF in
GOFNotch1 mice are less supportive to melanoma invasion.
Null Notch1 in CAF does not affect melanoma growth
To study the role of CAF with null Notch1 in regulating melanoma growth and invasion, we
created the 2nd pair of LOFNotch1 vs. LOFctrl mice. LOFNotch1 mice were also viable throughout
Fig 2. CAF inhibit melanoma invasion in GOFNotch1 mice. A. Left: decreased tumor invasion in GOFNotch1 compared with GOFctrl mice. Right: two
representative H&E images of tumor sections (n = 8/group). Dash lines indicate tumor boundaries. Arrows point to invading tumor cells. Percentage of
invasion is based on results of H&E staining in low power fields (LPF) of each tumor section.B. Fibroblasts in the melanoma capsule have lower proliferative
activity (less Ki67+/FSP1+ cells) in GOFNotch1 than in GOFctrl mice. C. Quantification of Ki67+ fibroblasts/HPF in the melanoma capsule of GOFNotch1 (black
bar) vs. GOFctrl (white bar) mice. Results are counts from 5 HPF per section and 5 section/tumor. The data were analyzed using two-tailed Student’s t-test
and expressed as the mean ± SD.
doi:10.1371/journal.pone.0142815.g002
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the melanoma skin graft experiments and their body appearance and skin tissue histology
appeared normal (S2A Fig).
N1IC and Hes1 were undetectable in FSP1+ skin fibroblasts of LOFNotch1 mice while slightly
detectable in skin of LOFctrl mice (Fig 3A, S2B Fig). N1IC was also undetectable in fibroblasts at
melanoma capsule in LOFNotch1 mice (melanoma cells express high levels of N1IC as previously
reported [13], serving as an internal control for N1IC expression), but marginally detectable in
LOFctrl mice (Fig 3B). These data indicate the inactivated status of the Notch1 signaling caused
by Notch1 deletion in fibroblasts of LOFNotch1 mice vs. basal level status of Notch1 signaling in
fibroblasts of LOFctrl mice. In addition, Western blotting analysis validated successful deletion
of Notch1 in skin fibroblasts of LOFNotch1 mice. Expression of full-length of Notch1 (271Kd)
Fig 3. CAF do not affect melanoma growth in LOFNotch1 mice. A. Undetectable vs. marginally detectable N1IC expression in skin fibroblasts of LOFNotch1
vs. LOFctrl mice. Arrowheads point to nuclear staining of N1IC in fibroblasts. B. Undetectable vs. detectable N1IC as pointed by arrowheads in fibroblasts at
melanoma capsule in LOFNotch1 vs. LOFctrl mice.C. Undetectable full-length of Notch1 protein (271Kd) and slight amount of N1IC (120 Kd, which was likely
presented in non-fibroblasts) in skin tissue of LOFNotch1 mice was exhibited byWestern blotting analysis. β–actin was used as loading control.D. Melanoma
growth is comparable in LOFNotch1 and LOFctrl mice (n = 8/group). Five representative images of tumors/group are showed. E. Numbers of Ki67+ tumor cells
are comparable in LOFNotch1 (black bar) and LOFctrl (white bar) mice. Quantifications are counts from 5 HPF per section and 5 section/tumor. The data were
statistically analyzed using two-tailed Student’s t-test and expressed as the mean ± SD.
doi:10.1371/journal.pone.0142815.g003
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was undetectable in LOFNotch1 mice, although there was slight presence of N1IC (120Kd) (Fig
3C). The marginal levels of N1IC in skin of LOFctrl mice were ascribed to the presence of N1IC
in non-fibroblasts in skin tissue.
To investigate the role of CAF with low or none Notch1 activity in regulating melanoma
progression, 5 x 105 Luc2+/B16-F10 cells were inoculated (s.c.) on dorsal skin of 8-week old
LOFNotch1 vs. LOFctrl mice. Melanoma skin graft and measurement of tumor growth, invasion
and metastasis were conducted identically as described above. The sizes of tumor grafts
resected from LOFNotch1 are comparable to that from LOFctrl mice (Fig 3D). Consistently, there
was no significant difference in numbers of Ki67+ tumor cells (Luc2+) within melanoma tissues
(Fig 3E) in LOFNotch1 vs. LOFctrl mice. These results showed that CAF in LOFNotch1 mice has
little effect on melanoma skin growth.
CAF promotes melanoma invasion in LOFNotch1 mice
In contrast, engrafted melanoma had increased local invasion rates in LOFNotch1 (75%) mice
than in LOFctrl (30%) mice (Fig 4A) as evaluated by histological assessment of tissue sections of
resected tumor, indicating that CAF promote melanoma invasion in LOFNotch1 mice. Consis-
tently, fibroblasts surrounding the tumor in LOFNotch1 mice exhibited stronger activity (more
Ki67+/FSP1+ cells) than that in LOFctrl mice (Fig 4B), suggesting that CAF are more active and
may favor melanoma invasion in LOFNotch1 mice. Not surprisingly, no distant metastasis was
detectable in both sets of mice (data not shown), since the incidence of spontaneous metastasis
of grafted B16 cells is very low in the syngeneic murine melanoma model. It typically needs
resection of the primary tumor in order for formation of distant metastases to occur [19].
Alternatively, it may be insufficient for a full course of metastasis to be completed within the
time frame (3-weeks) of our experiments. Overall, our results demonstrate that deletion of
Notch1 in CAF enhances their regulatory effect on melanoma invasion.
Discussion
Grafting B16-F10 cells onto skin of GOFNotch1 and LOFNotch1 mice offer unique syngeneic
murine melanoma models for deciphering role of Notch1 signaling in governing tumor-regu-
lating function of CAF in TME in which the entire cellular components of tumor stroma are
composed of natural host cells. Our results defined Notch1 signaling as a molecular switch con-
trolling tumor-regulating function of CAF. Turning this molecular switch ON and OFF can
inversely confer tumor-suppressive and tumor-promoting properties on CAF. Hence, Notch
signaling may be manipulated to implement Notch signaling-directed therapy for melanoma,
and potentially other solid tumors. It thus opens a new avenue to target TME by either repro-
graming and converting CAF from ‘tumor promoters’ to ‘tumor suppressors’ through thera-
peutic activation of Notch1 pathway or directly exploiting Notch downstream mediator(s), i.e.
WISP1 [11]. Although there are numerous options for activation of Notch1 pathway in CAF,
such as using gene therapy approach or novel genome editing method, CRISPR/Cas9 or
CRISPR/Cpf1, to introduce N1IC, or applying Notch pathway activating compound, which can
be identified through a similar high-throughput screening method [20], activating Notch1 sig-
naling specifically in CAF, while not simultaneously increasing the Notch activity in melanoma
cells, pose a therapeutic challenge, as the biological function of Notch signaling is cell context-
dependent [21], and high Notch activity is oncogenic to melanoma [13]. It is unclear how
Notch signaling is differentially regulated in CAF and melanoma cells in a single microenviron-
ment. It also remains unclear whether Notch/ligands participate in cell-cell communication
between fibroblasts-melanoma cells. Since a significant fraction of CAF in tumor tissue are
derived from mesenchymal stem cells (MSC), an alternative strategy is to develop cell-based
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therapies by targeted delivery of therapeutic cells, i.e. autologous MSC-derived fibroblasts pre-
engineered ‘ex vivo’ to either carry high Notch1 activity using methods described above or
overexpress WISP1, into tumor tissue. Fibroblasts expressing high Notch activity tend to
undergo cell cycle arrest [9,10]. This character makes MSCD-SF carrying high Notch activity
more appealing as therapeutic cells, because they will not expand irresistibly after their homing
to tumor tissue and are eventually cleared by immune cells. Therefore, they can be repeatedly
applied to patients to enhance therapeutic efficacy.
Unlike the inhibitory effects of CAF in GOFNotch1 mice on both melanoma growth and
invasion, CAF in LOFNotch1 mice promote local invasion, but not skin growth of melanoma.
The mechanism for such distinct effects of CAF in GOFNotch1 mice vs. LOFNotch1 mice remains
unclear. Possibly, the growth and invasion properties of melanoma are regulated by different
Fig 4. CAF promotemelanoma invasion in LOFNotch1 mice. A. Left: Increased melanoma invasion in skin of LOFNotch1 vs. LOFctrl mice (n = 8/group).
Right: two representative H&E images of tumor sections per group are displayed. Dash lines indicate tumor boundaries. Arrows point to invading tumor cells.
Percentage of invasion is based on results of H&E staining in LPF of each tumor section.B. Null Notch1 CAF which surround tumors exhibit higher
proliferative activity as more Ki67+/FSP1+ cells are detectable in LOFNotch1 than in LOFctrl mice. C. Quantification of Ki67+ fibroblasts/HPF in melanoma
capsule of LOFNotch1 (black bar) vs. LOFctrl (white bar) mice. Quantifications are counts from 5 HPF per section and 5 section/tumor. The data were
statistically analyzed using two-tailed Student’s t-test and expressed as the mean ± SD.
doi:10.1371/journal.pone.0142815.g004
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soluble factors and microenvironmental cues created by CAF. Deletion of Notch1 in CAF may
result in change of a set of soluble factors and microenvironmental cues, which preferentially
or sufficiently affects melanoma invasion, but not growth property. On the other hand, soluble
factors and microenvironmental cues created by CAF, which determine melanoma growth
property, may not be exactly inverted between GOFNotch1 and LOFNotch1 mice. The Notch1
pathway is hyper-activated through expression of N1IC mutant in CAF of GOFNotch1 mice,
which is different from canonical, ligand-induced Notch1 activation where deletion of Notch1
may inversely mirror. This could explain why CAF in GOFNotch1 mice retarded melanoma
growth, while CAF in LOFNotch1 mice do not promote melanoma growth. Alternatively, other
Notch isoforms may compensate for Notch1 loss in CAF of LOFNotch1 mice. Future studies are
warranted to examine complete profiles of soluble factors and microenvironmental cues deter-
mined by different CAF (CAF from GOFNotch1 mice vs. CAF from GOFCtrl mice and CAF
from LOFNotch1 mice vs. CAF from LOFCtrl mice).
Another interesting, yet unexplained finding is the distinct spontaneous invasion rates of
B16-F10 cells grafted on GOFCtrl (83.3%) vs. LOFCtrl (30%) mice, possibly due to the different
genetic backgrounds of two lines of mice. MSC-derived fibroblasts from these two lines of con-
trol mice also exhibit different tumor-regulating phenotypes in vitro. Fibroblasts from GOFCtrl
mice induced melanoma cells to form spheroids while those from LOFCtrl mice did not
(unpublished observation).
In summary, we uncover the Notch1 pathway as a molecular determinant that controls the
regulatory role of CAF in melanoma growth and invasion. Our study highlights the Notch1
pathway as a potential therapeutic target to be manipulated to reprogram and convert CAF to
act as tumor suppressors. These findings warrant future study to elucidate molecular mecha-
nisms for the Notch1-determined tumor-regulating role in CAF.
Supporting Information
S1 Fig. A, Representative appearance pictures of GOFNotch1 and GOFCtrl. Skin tissue histol-
ogy appears normal as examined by H&E at week 6. B, Elevated expression of Hey1 in skin
fibroblasts of GOFNotch1 mice compared with GOFCtrl mice. Arrowheads point to nuclear-
localized Hey1 in fibroblasts. Antibody recognizes Hey-1 was purchased from GeneTex
(GTX42614).
(PDF)
S2 Fig. A, Representative appearance pictures of LOFNotch1 and LOFCtrl. Skin tissue histol-
ogy appears normal as examined by H&E at week 6. B,Hes1 expression is undetectable in
fibroblasts located at capsule of melanoma in LOFNotch1 mice but slightly detectable at cap-
sule of melanoma LOFCtrl mice. Arrowheads point to nuclear-localized Hes1 in fibroblasts.
Antibody recognizes Hes1 was purchased from Abcam (ab71559).
(PDF)
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